Part 2 of 5: How the Carilion / Virginia Tech Model demonstrates that strategic collaboration generates superior outcomes compared to competitive models
The Competition Myth That’s Limiting Healthcare Innovation
For generations, academic medical centers have operated under a fundamental assumption: competition drives excellence. Institutions compete for the brightest faculty, the most prestigious research grants, and the highest-profile clinical trials. This competitive model has produced remarkable individual achievements, but it’s also created inefficiencies, duplicated efforts, and artificial barriers that slow the translation of discoveries into patient care.
What if this foundational assumption is wrong? What if the most significant breakthroughs in healthcare innovation come not from institutions competing against each other, but from institutions collaborating with each other?
The Carilion / Virginia Tech Model provides compelling evidence that strategic collaboration can generate competitive advantages that individual institutions, no matter how well-resourced, cannot achieve independently. This isn’t just cooperation—it’s intentional integration that creates capabilities greater than the sum of institutional parts.
The Four Pillars of Healthcare Innovation Collaboration
Analysis of the Carilion / Virginia Tech Model reveals four essential pillars that enable collaborative partnerships to outperform traditional competitive approaches:
Pillar 1: Complementary Asset Integration
The most successful healthcare innovation collaborations combine institutions with complementary rather than competing strengths. Virginia Tech brought world-class engineering capabilities, research infrastructure, and a culture of innovation. Carilion Clinic contributed clinical expertise, patient populations, and healthcare delivery experience. Rather than attempting to replicate each other’s capabilities, each institution focused on its core strengths while integrating with their partner’s expertise.
This complementary approach enables speed and efficiency that neither institution could achieve independently. When biomedical engineers at Virginia Tech develop a new medical device concept, they can immediately access clinical input from Carilion physicians who understand real-world applications. When Carilion clinicians identify treatment gaps, they can tap into Virginia Tech’s engineering capabilities to develop solutions.
The Fralin Biomedical Research Institute exemplifies this integration. Established as a shared enterprise rather than a Virginia Tech initiative hosted at Carilion, the institute operates with governance structures that ensure both institutions’ priorities are represented while pursuing breakthrough discoveries that benefit patients worldwide.
The Scale of Success: Under the leadership of Executive Director Michael Friedlander, the FBRI now encompasses 45 distinct research teams with 685 personnel including faculty, staff, and students. With an average annual salary of $105,000 for faculty and staff, the institute has created a substantial high-wage employment base that demonstrates the economic viability of collaborative research excellence.
Pillar 2: Shared Governance and Aligned Incentives
Successful collaboration requires governance structures that align institutional incentives around shared outcomes rather than individual institutional advancement. The Virginia Tech Carilion School of Medicine operates under joint governance that ensures both institutions benefit from success while sharing accountability for challenges.
This shared governance approach fundamentally changes decision-making by creating incentives for collective impact over individual institutional metrics. Faculty appointments, research priorities, and resource allocation reflect joint priorities rather than competing agendas, enabling rapid response when opportunities arise.
Success Story: Rapid COVID-19 Response
During the pandemic, the Carilion / Virginia Tech Model’s collaborative infrastructure enabled rapid response that demonstrated the power of integrated decision-making. The shared governance structure allowed researchers to pivot immediately to pandemic-related research while maintaining ongoing studies, resulting in multiple COVID-19 research initiatives that combined Virginia Tech’s engineering expertise with Carilion’s clinical insights. This collaborative approach enabled faster institutional response times compared to traditional single-institution models that require extensive inter-institutional negotiations for joint research initiatives.
Pillar 3: Resource Sharing and Risk Distribution
Healthcare innovation requires significant upfront investment with uncertain returns. Traditional institutional models require each organization to bear full financial risk for innovation initiatives, which often leads to conservative decision-making and slower progress.
The Carilion / Virginia Tech Model demonstrates how collaborative partnerships can share both resources and risks, enabling more ambitious innovation initiatives than either institution could pursue independently. The combined investment in research infrastructure, clinical facilities, and educational programs has exceeded $800 million from both public and private sources—a scale that would be difficult for either institution to achieve alone.
Financial Performance Metrics: The FBRI’s current financial profile demonstrates the success of this collaborative approach (with appreciation to Executive Director Michael Friedlander for providing the latest institutional data):
- Current active portfolio: $241 million across all grants and contracts
- Annual grants/contracts: $51 million in new funding annually
- Current year expenditures: $76 million supporting research operations
- Three-year expenditures: $212 million, demonstrating sustained investment
- Total expenditures since inception: $686 million in research activity
Economic Impact Multiplier: The institute generates substantial regional economic impact of $1.7 billion cumulative since inception, demonstrating a 2.5x multiplier effect on research expenditures.
This resource sharing extends beyond capital investment to include intellectual assets, specialized expertise, and operational capabilities. Rather than each institution maintaining duplicate capabilities, the collaborative model enables specialization and efficiency that generates superior outcomes at a lower cost per institution.
The success of this approach has attracted significant state investment through GO Virginia’s Project VITAL (Virginia Innovations and Technology Advancements in Life Sciences), which awarded $14.3 million to support cross-regional collaboration, according to state announcements in 2025. Project VITAL represents an approach where collaborative healthcare innovation can scale beyond individual partnerships to create corridor-wide networks spanning multiple regions and connecting Virginia Tech’s various campuses with clinical partners, community colleges, and industry.
Pillar 4: Network Effects and External Relationships
The most powerful advantage of collaborative models may be their ability to attract additional partnerships and resources that individual institutions cannot access. The Carilion / Virginia Tech partnership has catalyzed relationships with organizations ranging from Children’s National Hospital to pharmaceutical companies to federal research agencies.
These network effects create momentum that individual institutions struggle to generate. When external partners see successful collaboration between regional institutions, they gain confidence in the ecosystem’s stability and capabilities. This confidence translates into additional investment, research partnerships, and talent attraction that benefit all participating institutions.
Industry Validation: The partnership’s success has attracted major industry recognition, including Johnson & Johnson Innovation’s decision to establish JLABS collaboration with the Virginia Tech Corporate Research Center. This partnership provides regional startups with access to JLABS programming, resources, and mentorship, directly linking Southwest Virginia’s innovation ecosystem to one of the world’s leading pharmaceutical companies.
Media Recognition: The institute’s discoveries have achieved national and international recognition through coverage by major media organizations including The New York Times, The Washington Post, The Wall Street Journal, USA Today, Forbes, CNN, BBC, ABC’s Good Morning America, CBS Evening News/60 Minutes, NBC Nightly News, NPR’s All Things Considered, Discovery, National Geographic, Bloomberg, Associated Press, and Reuters.
Learning from Excellence: What Makes the Carilion / Virginia Tech Model Distinctive
The Carilion / Virginia Tech Model builds on lessons learned from world-class healthcare institutions while addressing unique challenges that even the most successful systems face:
Mayo Clinic: Represents the gold standard for integrated clinical care and has pioneered collaborative approaches within their system through the Mayo Clinic Care Network, which leverages their expertise as a consultative clinical partner to create scalable care models. The Carilion / Virginia Tech Model extends this integration concept across independent institutions, creating a replicable framework for regions without Mayo’s century-long institutional development and massive resource base.
Partners HealthCare / Mass General Brigham: Demonstrates exceptional clinical and research excellence within the Boston ecosystem, with over $2 billion in annual research funding and more than 3,700 ongoing clinical trials. The Southwest Virginia approach shows how similar collaboration can be achieved in non-metropolitan areas without requiring the concentration of resources available in major urban centers.
Cleveland Clinic: Leads in clinical innovation and operational excellence through their distinctive physician-led, salaried group practice model and continuous improvement culture. The Carilion / Virginia Tech Model complements this clinical focus with deep engineering integration, creating capabilities for medical device development and rapid prototyping that enhance traditional clinical excellence.
What distinguishes the Carilion / Virginia Tech Model is not superiority over these exceptional institutions, but rather its demonstration that collaborative excellence can be achieved in smaller communities through strategic partnerships. This creates opportunities for regions worldwide that cannot replicate Boston’s or Cleveland’s institutional density but can adapt Southwest Virginia’s collaborative framework to their local assets and community needs.
Workforce Development Excellence
Educational Impact: The collaborative model has produced extraordinary educational outcomes through the nationally award-winning Translational Biology, Medicine and Health (TBMH) graduate program. The program has graduated 104 students (over 90% with doctoral degrees) with remarkable career outcomes:
- 40% have secured research positions at major universities including Duke, Emory, Johns Hopkins, Harvard, Mayo Clinic, Stanford, UC Berkeley, UC San Francisco, University of Michigan, University of North Carolina, University of Pittsburgh, University of Virginia, Vanderbilt, Virginia Tech, and Yale
- 20% have joined pharmaceutical or medical device companies and biotech startups
- Others have taken positions with federal agencies (CDC, FDA, NIH, Walter Reed Army Medical Center), private foundations (Aspen Institute, American Academy of Arts and Sciences, American Association for the Advancement of Science), and health systems (Carilion Clinic, VA Boston Healthcare, Inova Health System)
Entrepreneurship Success: The institute has launched ten startup companies in Roanoke that have been awarded multiple small business grants, demonstrating the model’s capability to translate research discoveries into commercial applications that benefit the regional economy.
Faculty Excellence: FBRI faculty have achieved national and international recognition, including election as Senior Member of the National Academy of Inventors, Children’s Cancer Research Fund Emerging Scientist Award, Fellow of the Biomedical Engineering Society, Fellow of American Institute for Medical & Biological Engineering, Fellow of the American Society for Clinical Investigation, Fellows of the American Association for the Advancement of Science, Fellows of the American Psychological Association, Fellow of the College on Problems of Drug Dependence, Fellow of the Society for Experimental Biology and Medicine, Distinguished Scientist of the Society for Experimental Biology and Medicine, Alfred P. Sloan Foundation fellows, Kavli Fellows of the National Academy of Sciences, Fellow of the American Heart Association, elected fellow of the Heart Rhythm Society, and elected fellow of the American Association on Intellectual and Developmental Disabilities.
Implementation Framework: Building Collaborative Advantage
For healthcare leaders considering collaborative approaches, the Carilion / Virginia Tech Model suggests a systematic implementation framework:
Phase 1: Assessment and Alignment (6-12 months)
- Identify potential partner institutions with complementary capabilities
- Assess leadership commitment to genuine collaboration versus competitive positioning
- Establish shared vision and success metrics that benefit all participating institutions
- Develop governance structures that ensure equitable representation and decision-making
Phase 2: Pilot Project Development (12-18 months)
- Launch limited-scope collaborative initiatives that demonstrate partnership potential
- Build operational relationships and communication protocols between institutions
- Establish joint funding mechanisms and resource-sharing agreements
- Measure outcomes and refine collaboration processes based on experience
Phase 3: Strategic Integration (2-5 years)
- Expand successful pilot projects into comprehensive partnership agreements
- Develop shared infrastructure and joint programs that require ongoing collaboration
- Attract external funding and partnerships that support collaborative initiatives
- Build institutional culture and staff capabilities that support long-term partnership
Phase 4: Network Expansion (5+ years)
- Add additional institutional partners that enhance collaborative capabilities
- Develop replication models that can be adapted to other regions and contexts
- Establish thought leadership and best practice sharing with other collaborative networks
- Create sustainable competitive advantages that continue generating benefits long-term
Key Success Metrics
| Metric | Performance | Source |
| Research Teams | 45 active research teams | FBRI, 2024 |
| Personnel | 685 faculty, staff, and students | FBRI, 2024 |
| Active Grants | $241 million total active portfolio | FBRI, 2024 |
| Annual Funding | $51 million in new grants/contracts | FBRI, 2024 |
| Economic Impact | $1.7 billion cumulative since inception | FBRI, 2024 |
| Residency Match | 9 of 10 classes achieved 100% match | VTCSOM, 2024 |
Key Takeaways for Healthcare Leaders
For CEOs and Board Members:
- Active research portfolio: $241 million across 45 research teams with 685 personnel
- Economic impact: $1.7 billion cumulative return on $686 million investment
- Workforce development: 40% of doctoral graduates placed at major universities (Harvard, Johns Hopkins, Stanford)
For Clinical Leaders:
- Cross-institutional integration eliminates research-to-care handoff delays
- Talent attraction: $105,000 average salary attracts top researchers from leading institutions
- Quality outcomes: 100% residency match rate (9 of last 10 classes)
For Innovation Officers:
- Network effects: Johnson & Johnson JLABS partnership demonstrates external validation
- Commercialization success: 10 startup companies launched with small business grants
- Global recognition: Coverage by major media including New York Times, Washington Post, CNN
Taking the Carilion / Virginia Tech Model to the Next Level
The Future Vision: From Regional Success to Global Standard
The current success of the Carilion / Virginia Tech Model represents just the beginning of what collaborative healthcare innovation can achieve. As we look toward the next decade, the question isn’t whether this model works—the evidence is clear. The question is how to scale it to become the dominant paradigm for healthcare innovation worldwide.
The 2035 Vision: A potential network of interconnected regional healthcare innovation hubs, each built on the Carilion / Virginia Tech collaborative framework, sharing discoveries in real-time and accelerating breakthrough treatments. This represents a strategic projection based on current model success rather than a guaranteed outcome.*
Strategic projections and timelines presented in this analysis are based on current performance trends and represent potential outcomes rather than guaranteed results.
Strategic Expansion Pathways
Horizontal Scaling: The model’s next evolution involves replicating the framework across multiple regions while maintaining network connectivity. Rather than creating isolated successes, future implementations should be designed as nodes in a larger innovation network. Each regional hub would specialize in different therapeutic areas while sharing discoveries and resources.
Vertical Integration: Moving beyond institutional collaboration to include supply chains, regulatory partners, and global pharmaceutical networks. The JLABS partnership demonstrates early-stage vertical integration, but the future requires deeper integration with FDA processes, international regulatory bodies, and global clinical trial networks.
Digital Infrastructure: Future development may require sophisticated digital platforms that enable real-time collaboration across geographic boundaries. Potential applications include AI-powered research coordination, virtual reality clinical training, and blockchain-secured data sharing to transform how distributed teams collaborate on breakthrough discoveries.*
Technology projections represent potential development pathways based on current innovation trends rather than confirmed implementation plans.
Coming Next Week: In Part 1, we explored how geography no longer determines healthcare innovation success through the lens of Southwest Virginia’s unlikely emergence as a global innovation hub. Today, we shifted gears to examine the specific institutional partnership mechanics that enable breakthrough discoveries while serving authentic community needs.
Next week in Part 3, we’ll dive deep into the operational advantages of distributed research networks: “From Bench to Bedside in Record Time: The Distributed Research Advantage” — where we’ll explore how collaborative research networks can potentially accelerate clinical translation compared to traditional academic medical centers.*
Forward-looking statements in this analysis represent strategic projections based on current trends and performance data rather than guaranteed outcomes. Meaning I have no idea where the future will take us but I like the path we are on 😄.
References
Cardinal News. (2025, February 5). Project Vital bringing millions in funding to Roanoke-Blacksburg’s life sciences. Cardinal News. https://cardinalnews.org/2025/02/05/project-vital-bringing-millions-in-funding-to-roanoke-blacksburgs-life-sciences/
Fralin Biomedical Research Institute. (2024). About us. Virginia Tech. https://fbri.vtc.vt.edu/about.html
Mass General Brigham. (2024). Advancing care. https://www.massgeneralbrigham.org/en/about/advancing-care
Stoller, J. K., Goodman, D. M., Kondilis, B. K., & Laguna, T. A. (2014). The Cleveland Clinic: A distinctive model of American medicine. Academic Medicine, 89(11), 1457-1465.
Virginia Business. (2023, June 5). Small yet mighty. Virginia Business. https://virginiabusiness.com/small-yet-mighty/
Virginia Tech Carilion School of Medicine. (2024). Student match data. Virginia Tech. https://medicine.vtc.vt.edu/about/student-achievement.html
Virginia Tech Corporate Research Center. (2022). VT Corporate Research Center receives GO Virginia grant to expand lab facilities and resources. https://www.vtcrc.com/news/cogrolabs/
Virginia Tech News. (2023, March 19). Medical students celebrate Match Day in rock-star fashion. Virginia Tech News. https://news.vt.edu/articles/2023/03/vtcsom-match-day-2023.html
Virginia Tech News. (2025, February 10). Statewide initiative aims to position Virginia as a leading hub for biotechnology innovation. Virginia Tech News. https://news.vt.edu/articles/2025/02/outreach-gova-project-vital.html
Wald, J. T., Lowery-Schrandt, S., Hayes, D. L., & Kotsenas, A. L. (2018). Mayo Clinic Care Network: A collaborative health care model. Journal of the American College of Radiology, 15(1), 167-172.
This is the second post in a five-part series examining the Carilion / Virginia Tech Model for healthcare innovation. Next week: “From Bench to Bedside in Record Time: The Distributed Research Advantage.”
Previous post: Why Geography No Longer Determines Healthcare Innovation Success
Leave a Reply